Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease. [electronic resource]
Producer: 20180108Description: 287-296 p. digitalISSN:- 1542-233X
- Administration, Topical
- Adult
- Aged
- Aged, 80 and over
- Double-Blind Method
- Female
- Fluorophotometry
- Humans
- Keratoconjunctivitis Sicca -- diagnosis
- Male
- Middle Aged
- Ophthalmic Solutions
- Prospective Studies
- Proteins -- adverse effects
- Receptors, Interleukin-1 -- antagonists & inhibitors
- Tears -- physiology
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.